Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Anthracycline Anticancer Drugs Market Research Report 2024

Global Anthracycline Anticancer Drugs Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-02-14

Pages: 91 Pages

Report ld: 2503962

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Anthracycline Anticancer Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anthracycline Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthracycline Anticancer Drugs.

Report Scope
The Anthracycline Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anthracycline Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anthracycline Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Anthracycline Anticancer Drugs Market Research Report 2024
Global Anthracycline Anticancer Drugs Companies Covered
Pfizer, Ebewe Pharma, Sicor Societa, Hanhui Pharmaceuticals, Hisun Pharmaceutical, New Time Pharmaceutical, Main Luck Pharmaceuticals, Jinyuan Pharmaceutical, Pude Pharmaceutical, Lingnan Pharmaceutical, CSPC OUYI Pharmaceutical, Beijing Union Pharmaceutical
Global Anthracycline Anticancer Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anthracycline Anticancer Drugs Market, Segment by Type
Daunorubicin

Adriamycin

Epirubicin

Pirarubicin

Aclarithromycin

Others
Global Anthracycline Anticancer Drugs Market, Segment by Application
Acute Leukemia

Lymphoma

Breast Cancer

Stomach Cancer

Soft Tissue Sarcoma

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anthracycline Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anthracycline Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 Anthracycline Anticancer Drugs Market Overview
    1.1 Product Overview and Scope of Anthracycline Anticancer Drugs
    1.2 Anthracycline Anticancer Drugs Segment by Type
        1.2.1 Global Anthracycline Anticancer Drugs Market Value Comparison by Type (2024-2030)
        1.2.2 Daunorubicin
        1.2.3 Adriamycin
        1.2.4 Epirubicin
        1.2.5 Pirarubicin
        1.2.6 Aclarithromycin
        1.2.7 Others
    1.3 Anthracycline Anticancer Drugs Segment by Application
        1.3.1 Global Anthracycline Anticancer Drugs Market Value by Application: (2024-2030)
        1.3.2 Acute Leukemia
        1.3.3 Lymphoma
        1.3.4 Breast Cancer
        1.3.5 Stomach Cancer
        1.3.6 Soft Tissue Sarcoma
        1.3.7 Others
    1.4 Global Anthracycline Anticancer Drugs Market Size Estimates and Forecasts
        1.4.1 Global Anthracycline Anticancer Drugs Revenue 2019-2030
        1.4.2 Global Anthracycline Anticancer Drugs Sales 2019-2030
        1.4.3 Global Anthracycline Anticancer Drugs Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Anthracycline Anticancer Drugs Market Competition by Manufacturers
    2.1 Global Anthracycline Anticancer Drugs Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Anthracycline Anticancer Drugs Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Anthracycline Anticancer Drugs Average Price by Manufacturers (2019-2024)
    2.4 Global Anthracycline Anticancer Drugs Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Anthracycline Anticancer Drugs, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Anthracycline Anticancer Drugs, Product Type & Application
    2.7 Anthracycline Anticancer Drugs Market Competitive Situation and Trends
        2.7.1 Anthracycline Anticancer Drugs Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Anthracycline Anticancer Drugs Players Market Share by Revenue
        2.7.3 Global Anthracycline Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Anthracycline Anticancer Drugs Retrospective Market Scenario by Region
    3.1 Global Anthracycline Anticancer Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Anthracycline Anticancer Drugs Global Anthracycline Anticancer Drugs Sales by Region: 2019-2030
        3.2.1 Global Anthracycline Anticancer Drugs Sales by Region: 2019-2024
        3.2.2 Global Anthracycline Anticancer Drugs Sales by Region: 2025-2030
    3.3 Global Anthracycline Anticancer Drugs Global Anthracycline Anticancer Drugs Revenue by Region: 2019-2030
        3.3.1 Global Anthracycline Anticancer Drugs Revenue by Region: 2019-2024
        3.3.2 Global Anthracycline Anticancer Drugs Revenue by Region: 2025-2030
    3.4 North America Anthracycline Anticancer Drugs Market Facts & Figures by Country
        3.4.1 North America Anthracycline Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Anthracycline Anticancer Drugs Sales by Country (2019-2030)
        3.4.3 North America Anthracycline Anticancer Drugs Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Anthracycline Anticancer Drugs Market Facts & Figures by Country
        3.5.1 Europe Anthracycline Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Anthracycline Anticancer Drugs Sales by Country (2019-2030)
        3.5.3 Europe Anthracycline Anticancer Drugs Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Anthracycline Anticancer Drugs Market Facts & Figures by Country
        3.6.1 Asia Pacific Anthracycline Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Anthracycline Anticancer Drugs Sales by Country (2019-2030)
        3.6.3 Asia Pacific Anthracycline Anticancer Drugs Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Anthracycline Anticancer Drugs Market Facts & Figures by Country
        3.7.1 Latin America Anthracycline Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Anthracycline Anticancer Drugs Sales by Country (2019-2030)
        3.7.3 Latin America Anthracycline Anticancer Drugs Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Anthracycline Anticancer Drugs Market Facts & Figures by Country
        3.8.1 Middle East and Africa Anthracycline Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Anthracycline Anticancer Drugs Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Anthracycline Anticancer Drugs Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Anthracycline Anticancer Drugs Sales by Type (2019-2030)
        4.1.1 Global Anthracycline Anticancer Drugs Sales by Type (2019-2024)
        4.1.2 Global Anthracycline Anticancer Drugs Sales by Type (2025-2030)
        4.1.3 Global Anthracycline Anticancer Drugs Sales Market Share by Type (2019-2030)
    4.2 Global Anthracycline Anticancer Drugs Revenue by Type (2019-2030)
        4.2.1 Global Anthracycline Anticancer Drugs Revenue by Type (2019-2024)
        4.2.2 Global Anthracycline Anticancer Drugs Revenue by Type (2025-2030)
        4.2.3 Global Anthracycline Anticancer Drugs Revenue Market Share by Type (2019-2030)
    4.3 Global Anthracycline Anticancer Drugs Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Anthracycline Anticancer Drugs Sales by Application (2019-2030)
        5.1.1 Global Anthracycline Anticancer Drugs Sales by Application (2019-2024)
        5.1.2 Global Anthracycline Anticancer Drugs Sales by Application (2025-2030)
        5.1.3 Global Anthracycline Anticancer Drugs Sales Market Share by Application (2019-2030)
    5.2 Global Anthracycline Anticancer Drugs Revenue by Application (2019-2030)
        5.2.1 Global Anthracycline Anticancer Drugs Revenue by Application (2019-2024)
        5.2.2 Global Anthracycline Anticancer Drugs Revenue by Application (2025-2030)
        5.2.3 Global Anthracycline Anticancer Drugs Revenue Market Share by Application (2019-2030)
    5.3 Global Anthracycline Anticancer Drugs Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Pfizer Anthracycline Anticancer Drugs Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
    6.2 Ebewe Pharma
        6.2.1 Ebewe Pharma Corporation Information
        6.2.2 Ebewe Pharma Description and Business Overview
        6.2.3 Ebewe Pharma Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Ebewe Pharma Anthracycline Anticancer Drugs Product Portfolio
        6.2.5 Ebewe Pharma Recent Developments/Updates
    6.3 Sicor Societa
        6.3.1 Sicor Societa Corporation Information
        6.3.2 Sicor Societa Description and Business Overview
        6.3.3 Sicor Societa Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Sicor Societa Anthracycline Anticancer Drugs Product Portfolio
        6.3.5 Sicor Societa Recent Developments/Updates
    6.4 Hanhui Pharmaceuticals
        6.4.1 Hanhui Pharmaceuticals Corporation Information
        6.4.2 Hanhui Pharmaceuticals Description and Business Overview
        6.4.3 Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Product Portfolio
        6.4.5 Hanhui Pharmaceuticals Recent Developments/Updates
    6.5 Hisun Pharmaceutical
        6.5.1 Hisun Pharmaceutical Corporation Information
        6.5.2 Hisun Pharmaceutical Description and Business Overview
        6.5.3 Hisun Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Hisun Pharmaceutical Anthracycline Anticancer Drugs Product Portfolio
        6.5.5 Hisun Pharmaceutical Recent Developments/Updates
    6.6 New Time Pharmaceutical
        6.6.1 New Time Pharmaceutical Corporation Information
        6.6.2 New Time Pharmaceutical Description and Business Overview
        6.6.3 New Time Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 New Time Pharmaceutical Anthracycline Anticancer Drugs Product Portfolio
        6.6.5 New Time Pharmaceutical Recent Developments/Updates
    6.7 Main Luck Pharmaceuticals
        6.6.1 Main Luck Pharmaceuticals Corporation Information
        6.6.2 Main Luck Pharmaceuticals Description and Business Overview
        6.6.3 Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Product Portfolio
        6.7.5 Main Luck Pharmaceuticals Recent Developments/Updates
    6.8 Jinyuan Pharmaceutical
        6.8.1 Jinyuan Pharmaceutical Corporation Information
        6.8.2 Jinyuan Pharmaceutical Description and Business Overview
        6.8.3 Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Product Portfolio
        6.8.5 Jinyuan Pharmaceutical Recent Developments/Updates
    6.9 Pude Pharmaceutical
        6.9.1 Pude Pharmaceutical Corporation Information
        6.9.2 Pude Pharmaceutical Description and Business Overview
        6.9.3 Pude Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 Pude Pharmaceutical Anthracycline Anticancer Drugs Product Portfolio
        6.9.5 Pude Pharmaceutical Recent Developments/Updates
    6.10 Lingnan Pharmaceutical
        6.10.1 Lingnan Pharmaceutical Corporation Information
        6.10.2 Lingnan Pharmaceutical Description and Business Overview
        6.10.3 Lingnan Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 Lingnan Pharmaceutical Anthracycline Anticancer Drugs Product Portfolio
        6.10.5 Lingnan Pharmaceutical Recent Developments/Updates
    6.11 CSPC OUYI Pharmaceutical
        6.11.1 CSPC OUYI Pharmaceutical Corporation Information
        6.11.2 CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Description and Business Overview
        6.11.3 CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.11.4 CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Product Portfolio
        6.11.5 CSPC OUYI Pharmaceutical Recent Developments/Updates
    6.12 Beijing Union Pharmaceutical
        6.12.1 Beijing Union Pharmaceutical Corporation Information
        6.12.2 Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Description and Business Overview
        6.12.3 Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.12.4 Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Product Portfolio
        6.12.5 Beijing Union Pharmaceutical Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Anthracycline Anticancer Drugs Industry Chain Analysis
    7.2 Anthracycline Anticancer Drugs Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Anthracycline Anticancer Drugs Production Mode & Process
    7.4 Anthracycline Anticancer Drugs Sales and Marketing
        7.4.1 Anthracycline Anticancer Drugs Sales Channels
        7.4.2 Anthracycline Anticancer Drugs Distributors
    7.5 Anthracycline Anticancer Drugs Customers

 8 Anthracycline Anticancer Drugs Market Dynamics
    8.1 Anthracycline Anticancer Drugs Industry Trends
    8.2 Anthracycline Anticancer Drugs Market Drivers
    8.3 Anthracycline Anticancer Drugs Market Challenges
    8.4 Anthracycline Anticancer Drugs Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Anthracycline Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Anthracycline Anticancer Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Anthracycline Anticancer Drugs Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Anthracycline Anticancer Drugs Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Anthracycline Anticancer Drugs Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Anthracycline Anticancer Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Anthracycline Anticancer Drugs Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Anthracycline Anticancer Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Anthracycline Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Anthracycline Anticancer Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Anthracycline Anticancer Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Anthracycline Anticancer Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anthracycline Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthracycline Anticancer Drugs as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anthracycline Anticancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Anthracycline Anticancer Drugs Sales by Region (2019-2024) & (K Units)
    Table 18. Global Anthracycline Anticancer Drugs Sales Market Share by Region (2019-2024)
    Table 19. Global Anthracycline Anticancer Drugs Sales by Region (2025-2030) & (K Units)
    Table 20. Global Anthracycline Anticancer Drugs Sales Market Share by Region (2025-2030)
    Table 21. Global Anthracycline Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Anthracycline Anticancer Drugs Revenue Market Share by Region (2019-2024)
    Table 23. Global Anthracycline Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Anthracycline Anticancer Drugs Revenue Market Share by Region (2025-2030)
    Table 25. North America Anthracycline Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Anthracycline Anticancer Drugs Sales by Country (2019-2024) & (K Units)
    Table 27. North America Anthracycline Anticancer Drugs Sales by Country (2025-2030) & (K Units)
    Table 28. North America Anthracycline Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Anthracycline Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Anthracycline Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Anthracycline Anticancer Drugs Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Anthracycline Anticancer Drugs Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Anthracycline Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Anthracycline Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Anthracycline Anticancer Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Anthracycline Anticancer Drugs Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Anthracycline Anticancer Drugs Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Anthracycline Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Anthracycline Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Anthracycline Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Anthracycline Anticancer Drugs Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Anthracycline Anticancer Drugs Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Anthracycline Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Anthracycline Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Anthracycline Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Anthracycline Anticancer Drugs Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Anthracycline Anticancer Drugs Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Anthracycline Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Anthracycline Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Anthracycline Anticancer Drugs Sales (K Units) by Type (2019-2024)
    Table 51. Global Anthracycline Anticancer Drugs Sales (K Units) by Type (2025-2030)
    Table 52. Global Anthracycline Anticancer Drugs Sales Market Share by Type (2019-2024)
    Table 53. Global Anthracycline Anticancer Drugs Sales Market Share by Type (2025-2030)
    Table 54. Global Anthracycline Anticancer Drugs Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Anthracycline Anticancer Drugs Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Anthracycline Anticancer Drugs Revenue Market Share by Type (2019-2024)
    Table 57. Global Anthracycline Anticancer Drugs Revenue Market Share by Type (2025-2030)
    Table 58. Global Anthracycline Anticancer Drugs Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Anthracycline Anticancer Drugs Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Anthracycline Anticancer Drugs Sales (K Units) by Application (2019-2024)
    Table 61. Global Anthracycline Anticancer Drugs Sales (K Units) by Application (2025-2030)
    Table 62. Global Anthracycline Anticancer Drugs Sales Market Share by Application (2019-2024)
    Table 63. Global Anthracycline Anticancer Drugs Sales Market Share by Application (2025-2030)
    Table 64. Global Anthracycline Anticancer Drugs Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Anthracycline Anticancer Drugs Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Anthracycline Anticancer Drugs Revenue Market Share by Application (2019-2024)
    Table 67. Global Anthracycline Anticancer Drugs Revenue Market Share by Application (2025-2030)
    Table 68. Global Anthracycline Anticancer Drugs Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Anthracycline Anticancer Drugs Price (US$/Unit) by Application (2025-2030)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Pfizer Anthracycline Anticancer Drugs Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. Ebewe Pharma Corporation Information
    Table 76. Ebewe Pharma Description and Business Overview
    Table 77. Ebewe Pharma Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Ebewe Pharma Anthracycline Anticancer Drugs Product
    Table 79. Ebewe Pharma Recent Developments/Updates
    Table 80. Sicor Societa Corporation Information
    Table 81. Sicor Societa Description and Business Overview
    Table 82. Sicor Societa Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Sicor Societa Anthracycline Anticancer Drugs Product
    Table 84. Sicor Societa Recent Developments/Updates
    Table 85. Hanhui Pharmaceuticals Corporation Information
    Table 86. Hanhui Pharmaceuticals Description and Business Overview
    Table 87. Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Product
    Table 89. Hanhui Pharmaceuticals Recent Developments/Updates
    Table 90. Hisun Pharmaceutical Corporation Information
    Table 91. Hisun Pharmaceutical Description and Business Overview
    Table 92. Hisun Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Hisun Pharmaceutical Anthracycline Anticancer Drugs Product
    Table 94. Hisun Pharmaceutical Recent Developments/Updates
    Table 95. New Time Pharmaceutical Corporation Information
    Table 96. New Time Pharmaceutical Description and Business Overview
    Table 97. New Time Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. New Time Pharmaceutical Anthracycline Anticancer Drugs Product
    Table 99. New Time Pharmaceutical Recent Developments/Updates
    Table 100. Main Luck Pharmaceuticals Corporation Information
    Table 101. Main Luck Pharmaceuticals Description and Business Overview
    Table 102. Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Product
    Table 104. Main Luck Pharmaceuticals Recent Developments/Updates
    Table 105. Jinyuan Pharmaceutical Corporation Information
    Table 106. Jinyuan Pharmaceutical Description and Business Overview
    Table 107. Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Product
    Table 109. Jinyuan Pharmaceutical Recent Developments/Updates
    Table 110. Pude Pharmaceutical Corporation Information
    Table 111. Pude Pharmaceutical Description and Business Overview
    Table 112. Pude Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Pude Pharmaceutical Anthracycline Anticancer Drugs Product
    Table 114. Pude Pharmaceutical Recent Developments/Updates
    Table 115. Lingnan Pharmaceutical Corporation Information
    Table 116. Lingnan Pharmaceutical Description and Business Overview
    Table 117. Lingnan Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Lingnan Pharmaceutical Anthracycline Anticancer Drugs Product
    Table 119. Lingnan Pharmaceutical Recent Developments/Updates
    Table 120. CSPC OUYI Pharmaceutical Corporation Information
    Table 121. CSPC OUYI Pharmaceutical Description and Business Overview
    Table 122. CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Product
    Table 124. CSPC OUYI Pharmaceutical Recent Developments/Updates
    Table 125. Beijing Union Pharmaceutical Corporation Information
    Table 126. Beijing Union Pharmaceutical Description and Business Overview
    Table 127. Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Product
    Table 129. Beijing Union Pharmaceutical Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Anthracycline Anticancer Drugs Distributors List
    Table 133. Anthracycline Anticancer Drugs Customers List
    Table 134. Anthracycline Anticancer Drugs Market Trends
    Table 135. Anthracycline Anticancer Drugs Market Drivers
    Table 136. Anthracycline Anticancer Drugs Market Challenges
    Table 137. Anthracycline Anticancer Drugs Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anthracycline Anticancer Drugs
    Figure 2. Global Anthracycline Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Anthracycline Anticancer Drugs Market Share by Type in 2023 & 2030
    Figure 4. Daunorubicin Product Picture
    Figure 5. Adriamycin Product Picture
    Figure 6. Epirubicin Product Picture
    Figure 7. Pirarubicin Product Picture
    Figure 8. Aclarithromycin Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Anthracycline Anticancer Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global Anthracycline Anticancer Drugs Market Share by Application in 2023 & 2030
    Figure 12. Acute Leukemia
    Figure 13. Lymphoma
    Figure 14. Breast Cancer
    Figure 15. Stomach Cancer
    Figure 16. Soft Tissue Sarcoma
    Figure 17. Others
    Figure 18. Global Anthracycline Anticancer Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Anthracycline Anticancer Drugs Market Size (2019-2030) & (US$ Million)
    Figure 20. Global Anthracycline Anticancer Drugs Sales (2019-2030) & (K Units)
    Figure 21. Global Anthracycline Anticancer Drugs Average Price (US$/Unit) & (2019-2030)
    Figure 22. Anthracycline Anticancer Drugs Report Years Considered
    Figure 23. Anthracycline Anticancer Drugs Sales Share by Manufacturers in 2023
    Figure 24. Global Anthracycline Anticancer Drugs Revenue Share by Manufacturers in 2023
    Figure 25. The Global 5 and 10 Largest Anthracycline Anticancer Drugs Players: Market Share by Revenue in 2023
    Figure 26. Anthracycline Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 27. Global Anthracycline Anticancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 28. North America Anthracycline Anticancer Drugs Sales Market Share by Country (2019-2030)
    Figure 29. North America Anthracycline Anticancer Drugs Revenue Market Share by Country (2019-2030)
    Figure 30. United States Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Canada Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Europe Anthracycline Anticancer Drugs Sales Market Share by Country (2019-2030)
    Figure 33. Europe Anthracycline Anticancer Drugs Revenue Market Share by Country (2019-2030)
    Figure 34. Germany Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. France Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. U.K. Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Italy Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Russia Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Asia Pacific Anthracycline Anticancer Drugs Sales Market Share by Region (2019-2030)
    Figure 40. Asia Pacific Anthracycline Anticancer Drugs Revenue Market Share by Region (2019-2030)
    Figure 41. China Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Japan Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. South Korea Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. India Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Australia Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Latin America Anthracycline Anticancer Drugs Sales Market Share by Country (2019-2030)
    Figure 49. Latin America Anthracycline Anticancer Drugs Revenue Market Share by Country (2019-2030)
    Figure 50. Mexico Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Brazil Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Argentina Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Middle East & Africa Anthracycline Anticancer Drugs Sales Market Share by Country (2019-2030)
    Figure 54. Middle East & Africa Anthracycline Anticancer Drugs Revenue Market Share by Country (2019-2030)
    Figure 55. Turkey Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. UAE Anthracycline Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. Global Sales Market Share of Anthracycline Anticancer Drugs by Type (2019-2030)
    Figure 59. Global Revenue Market Share of Anthracycline Anticancer Drugs by Type (2019-2030)
    Figure 60. Global Anthracycline Anticancer Drugs Price (US$/Unit) by Type (2019-2030)
    Figure 61. Global Sales Market Share of Anthracycline Anticancer Drugs by Application (2019-2030)
    Figure 62. Global Revenue Market Share of Anthracycline Anticancer Drugs by Application (2019-2030)
    Figure 63. Global Anthracycline Anticancer Drugs Price (US$/Unit) by Application (2019-2030)
    Figure 64. Anthracycline Anticancer Drugs Value Chain
    Figure 65. Anthracycline Anticancer Drugs Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed

Description

The global Anthracycline Anticancer Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anthracycline Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthracycline Anticancer Drugs.

Report Scope
The Anthracycline Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anthracycline Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anthracycline Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anthracycline Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anthracycline Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Industry: Pharma & Healthcare

Published: 2024-02-14

Pages: 91 Pages

Report ld: 2503962

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License